Abstract
N‐Methyl‐d‐aspartate (NMDA; 500 μM) stimulated the net release of preloaded tritiated norepinephrine from rat hippocampal slices. Both ethanol and the competitive glycine antagonist 7‐chlorokynurenic acid (7‐CK) dose‐dependently inhibited NMDA‐stimulated release without affecting basal, nonstimulated efflux. These inhibitory effects were readily reversed upon washout of the drugs. Over the concentration range tested (25–200 mM), ethanol inhibited ∼65% of NMDA‐stimulated release with an estimated IC50of ∼70 mM. In contrast, 7‐CK fully inhibited release (>95%) at a concentration of 30 μMwith half‐maximal inhibition occurring at ∼2 μM. The combination of 7‐CK (1–30 μM) and ethanol (25–100 mM) had an additive inhibitory effect on NMDA‐stimulated release but did not alter the inhibitory potency of 7‐CK. Calculated IC50values for 7‐CK in the presence of 25, 50, or 100 mMethanol were (mean × SEM; μM) 2.33 (0.11), 2.38 (0.23), and 1.99 (0.30), respectively. 7‐CK (3 μM) inhibited NMDA‐stimulated [3H]norepinephrine release by ∼50%. This inhibition was fully attenuated by the addition of the glycine agonistserine with complete reversal occurring at 30 μMd‐serine. Increasing the 7‐CK concentration to 10 μMshifted thed‐serine dose‐effect curve to the right in a parallel fashion as expected for a competitive antagonist. In contrast, the inhibitory effects of ethanol or the combination of 7‐CK (3 μM) and ethanol (25 or 50 mM) were not reversed by the addition ofd‐serine (0.1–1,000 μM). Together, these results suggest that ethanol's inhibition of NMDA‐stimulated [3H]norepinephrine release from hippocampal slices is not due to a simple competitive interaction with the glycine site on the NMDA receptor.

This publication has 20 references indexed in Scilit: